These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2005-001166-13 A Phase I/II Open Label Study of the 17α-hydroxylase/ C17,20 lyase inhibitor, Abiraterone acetate, in Patients with Prostate Cancer who have failed hormone therapy 2008-11-20 due-trials
Reported results 2006-004571-36 A Phase II Open Label Study of CB7630 (Abiraterone Acetate) in Patients with Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy 2008-07-25 due-trials
Reported results 2007-002725-74 A Phase II Open Label Study of CB7630 (Abiraterone Acetate) and Prednisone in Patients with Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy 2009-09-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005837-13 A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisolone in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetax... 2012-10-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-008004-41 A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisolone in Asymptomatic or Mildly Symptomatic Patients with Metastatic Castration-Resistant Pros... 2017-05-01 bad-data